Pages that link to "Q45297046"

The following pages link to Loss of amine from platinum(II) complexes: implications for cisplatin inactivation, storage, and resistance (Q45297046):

Displaying 26 items.

• ESI mass spectrometry and X-ray diffraction studies of adducts between anticancer platinum drugs and hen egg white lysozyme (Q27643373) (← links)
• Photocytotoxic trans-diam(m)ine platinum(IV) diazido complexes more potent than their cis isomers (Q34105902) (← links)
• Mass spectrometry evidence for cisplatin as a protein cross-linking reagent (Q35091564) (← links)
• Development of a Nanoparticle-Embedded Chitosan Sponge for Topical and Local Administration of Chemotherapeutic Agents (Q35990617) (← links)
• Modeling anticancer drug-DNA interactions via mixed QM/MM molecular dynamics simulations (Q36514784) (← links)
• Functionalized milk-protein-coated magnetic nanoparticles for MRI-monitored targeted therapy of pancreatic cancer (Q37082778) (← links)
• Diazido mixed-amine platinum(IV) anticancer complexes activatable by visible-light form novel DNA adducts. (Q38315077) (← links)
• Bringing inorganic chemistry to life with inspiration from R. J. P. Williams (Q38560599) (← links)
• Glutathione binding to dirhodium tetraacetate: a spectroscopic, mass spectral and computational study of an anti-tumour compound. (Q38803067) (← links)
• Use of top-down and bottom-up Fourier transform ion cyclotron resonance mass spectrometry for mapping calmodulin sites modified by platinum anticancer drugs (Q39788547) (← links)
• Trans labilization of am(m)ine ligands from platinum(II) complexes by cancer cell extracts. (Q39909476) (← links)
• Effects of amine ligand bulk and hydrogen bonding on the rate of reaction of platinum(II) diamine complexes with key nucleotide and amino acid residues. (Q42275375) (← links)
• Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1. (Q43294554) (← links)
• Interactions of oxaliplatin with the cytoplasmic thiol containing ligand glutathione (Q43485083) (← links)
• Direct determination of the binding sites of cisplatin on insulin-like growth factor-1 by top-down mass spectrometry (Q43961118) (← links)
• In silico approach to cisplatin toxicity. Quantum chemical studies on platinum(II)-cysteine systems (Q46120022) (← links)
• The effect of the extracellular domain of human copper transporter (hCTR1) on cisplatin activation. (Q46456871) (← links)
• Trans effect and trans influence: importance of metal mediated ligand-ligand repulsion (Q46754891) (← links)
• Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss. (Q47716828) (← links)
• Formation of chelate structure between His-Met dipeptide and diaqua-cisplatin complex; DFT/PCM computational study (Q50104218) (← links)
• Interactions of the "piano-stool" [ruthenium(II)(η(6) -arene)(quinolone)Cl]( ) complexes with water; DFT computational study. (Q50210771) (← links)
• Thermodynamic and structural study of phenanthroline derivative ruthenium complex/DNA interactions: Probing partial intercalation and binding properties (Q51493303) (← links)
• Platinum Complexes as Anti-Cancer Drugs: Modeling of Structure, Activation and Function (Q58486684) (← links)
• Platinum and Palladium Polyamine Complexes as Anticancer Agents: The Structural Factor (Q58993871) (← links)
• Arsenoplatin-1 Is a Dual Pharmacophore Anticancer Agent (Q63888872) (← links)
• Non-empirical quantum chemical studies on electron transfer reactions in trans- and cis-diamminedichloroplatinum(II) complexes (Q84074835) (← links)